Reference10 articles.
1. Safety of Janus kinase (JAK) inhibitors in the short-term treatment of atopic dermatitis;Wood;Int J Dermatol,2021
2. Should atopic dermatitis patients starting JAK inhibitors take prophylactic acyclovir?;Shah;J Dermatol Treat,2021
3. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial;Simpson;Lancet,2020
4. Interferon-gamma: an overview of signals, mechanisms and functions;Schroder;J Leukoc Biol,2004
5. Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts;Onda;J Immunol,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. JAK-STAT pathway inhibitors in dermatology;Anais Brasileiros de Dermatologia;2023-09